Dedicated to multi-modality treatment of benign skull base tumors, Adaptive Hybrid Surgery helps to balance surgical risk with radiosurgical toxicity.
Brainlab has been innovating for over a quarter century in the areas of surgery and radiation therapy, developing hardware and software technology to help healthcare providers, physicians and their patients fight cancer and other conditions of the brain and body.
Dedicated to improving access to and consistency of medical treatment, Brainlab is a global company committed to improving patient outcomes.
Brainlab offers technology in the fields of radiotherapy and radiosurgery; image-guided craniomaxillofacial (CMF), ENT, orthopedic, spine, trauma, and neurosurgery; intraoperative imaging; integrated operating room solutions; treatment planning as well as medical image sharing and enhancement.
Follow Brainlab on Twitter, Facebook, LinkedIn and YouTube for company updates and the latest in Brainlab innovation.
